Incyte Corp
NASDAQ:INCY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
NASDAQ:INCY
Watchlist
Price: 71.72 USD 1.89% Market Closed
Market Cap: 13.8B USD
Have any thoughts about
Incyte Corp?
Write Note

P/OCF
Price to OCF

135.8
Current
20.7
Median
21.6
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
135.8
=
Market Cap
13.8B USD
/
Operating Cash Flow
101.8m USD
All Countries
Close
Market Cap P/OCF
US
Incyte Corp
NASDAQ:INCY
13.8B USD 135.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 316.7
US
Abbvie Inc
NYSE:ABBV
312.7B USD 18.9
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 21.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD -137.9
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 11.2
US
Epizyme Inc
F:EPE
94.1B EUR -470.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 31.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 19.1
US
Seagen Inc
F:SGT
39.3B EUR -75.9
NL
argenx SE
XBRU:ARGX
34.8B EUR -139.8

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More